SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,826,008 | +205.6% | 102,503 | +233.2% | 0.01% | +250.0% |
| Q2 2023 | $924,616 | -45.7% | 30,759 | -51.9% | 0.00% | -63.6% |
| Q3 2021 | $1,704,000 | +13.6% | 63,894 | +11.5% | 0.01% | 0.0% |
| Q1 2021 | $1,500,000 | -54.2% | 57,283 | -56.0% | 0.01% | -59.3% |
| Q4 2020 | $3,275,000 | +4.9% | 130,168 | -13.1% | 0.03% | +3.8% |
| Q3 2020 | $3,122,000 | -8.1% | 149,800 | +4.8% | 0.03% | -33.3% |
| Q2 2020 | $3,396,000 | +40.5% | 143,001 | +6.4% | 0.04% | -43.5% |
| Q1 2020 | $2,417,000 | +43.0% | 134,339 | +88.6% | 0.07% | +109.1% |
| Q4 2019 | $1,690,000 | +225.6% | 71,229 | +277.1% | 0.03% | +266.7% |
| Q3 2019 | $519,000 | -53.2% | 18,888 | -43.6% | 0.01% | -71.0% |
| Q2 2019 | $1,109,000 | +7.4% | 33,516 | +13.7% | 0.03% | 0.0% |
| Q1 2019 | $1,033,000 | -23.9% | 29,479 | -27.8% | 0.03% | -50.0% |
| Q4 2018 | $1,357,000 | -32.8% | 40,842 | +21.0% | 0.06% | +14.8% |
| Q2 2018 | $2,020,000 | +59.3% | 33,753 | +14.8% | 0.05% | +68.8% |
| Q2 2017 | $1,268,000 | – | 29,412 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |